[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![WallStSai Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::90807052.png) S A I ™️ [@WallStSai](/creator/twitter/WallStSai) on x 7082 followers
Created: 2025-06-22 23:45:08 UTC

CHINESE BIOTECH SCIWIND BIOSCIENCES SHOWCASES CHALLENGER TO $LLY ELI LILLY’S OBESITY DRUG

Once approved, Sciwind’s “ecnoglutide” will compete with Novo’s Wegovy and Eli Lilly’s Zepbound, as well as Innovent Biologics Inc in the China market 

$NVO $VKTX $XBI #GLP1

![](https://pbs.twimg.com/media/GuFewenX0AAfrE6.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1936933504345894921/c:line.svg)

**Related Topics**
[lly](/topic/lly)
[$xbi](/topic/$xbi)
[china](/topic/china)
[$1801hk](/topic/$1801hk)
[approved](/topic/approved)
[$lly](/topic/$lly)
[eli lilly](/topic/eli-lilly)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/WallStSai/status/1936933504345894921)